Latest

Positive results from the RETAIN-2 trial demonstrate that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients

Identify the limitations of patient tissue controls in genetic testing and examine the verification data supporting cell line-derived standards

A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignancies

Framework enables approval of individualized genome editing and RNA-based treatments when traditional trials aren’t feasible

Nationwide deployment of AISight® Dx aims to support fully digital workflows and AI-assisted diagnostics across anatomic pathology labs

DNA laboratories can use the samples to help train analysts and validate forensic tests

Integrated solution simplifies multi-layer molecular analysis, advancing precision medicine and translational research

FNIH Biomarkers Consortium “clock model” can use a single blood test to estimate the onset of symptoms within three to four years

The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.

Optimized DNA barcoding showed that similar-looking tumors can release different amounts of DNA into the bloodstream

The landscape of companion diagnostics is poised for transformative growth, driven by technological innovation, expanding therapeutic applications, and evolving regulatory support

The US–WHO collaboration has been critical in the country’s response to mpox, shown here, as well as Ebola, Marburg, flu, and COVID-19

A new pilot brings some automated treatment decisions from Medicare Advantage to traditional Medicare

Study finds that disparities generally narrowed from 1995–2014, but subsequently widened

The FDA is embracing a data-driven, patient-centered approach to clinical trials